MIR3157

Across TCGA pan-cancer cohorts, MIR3157 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR3157 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR3157 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR3157 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUSC show a favorable association.

BRCA, LUSC, and THCA are the cancer types where MIR3157 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	III,IV	0.961	0.850	.002	72	view →
LUSC	OS	Tertile	II,III,IV	0.903	0.697	.010	42	view →
THCA	OS	Tertile	IV	0.790	0.987	<.001	33	view →
CHOL	OS	Tertile	III,IV	0.136	0.859	.003	21	view →
DLBC	OS	Tertile	III,IV	0.157	0.727	.007	12	view →
LGG	DFS	Tertile	All	0.802	0.707	.014	12	view →
LUAD	OS	Tertile	All	0.800	0.668	.035	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
THYM	OS	Tertile	All	0.861	0.982	.022	9	view →
ACC	OS	Tertile	III,IV	0.318	0.781	.006	9	view →
LIHC	DFS	Tertile	II,III,IV	0.122	0.425	.007	9	view →
HNSC	DFS	Tertile	IV	0.871	0.630	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR3157–BRCA (DFS)

Open the BRCA breakdown →